Touch & Attention MRI Study

Status Completed

Clinical Trial Summary

This study will measure resting state network central nervous system activity by functional magnetic resonance imaging (fMRI) during 4 separate interactions with a clinician. 1.

Hypothesis 1. Because they are different sensory systems, there will be different patterns of Mirror Neuron System (MNS)and Resting State Network (RSN) Central Nervous System (CNS) activity for visual vs. tactile stimulation, regardless of Loving Kindness Meditation (LKM).

Hypothesis 2. Because of unconscious, non-verbal signals, such as the practitioner's facial expression and respiratory rate, subjects' patterns of MNS and RSN CNS activity will differ for LKM+ vs. LKM- stimulation for both visual and tactile interventions.

Hypothesis 3. Because there is greater opportunity to detect signals from two sensory systems than one, the differences between CNS MNS and RSN activity patterns for LKM+ and LKM- will be greater for combined visual + tactile than for either visual or tactile stimulation alone.

Clinical Trial Description

This project builds on our previous research to build a platform for a successful NIH proposal to address a key gap in our understanding of the mechanism of non-verbal clinician-patient communication on physiology and behavior. Social neuroscience is a rapidly growing area of research that offers unique opportunities to better understand the mechanisms underlying common observations about clinician-patient interactions.The purpose of this study is to better understand the CNS mechanisms underlying the observed changes in self-reported well-being and ANS activity by evaluating resting fMRI activity under controlled conditions. The specific aims are to compare resting fMRI activity in the mirror neuron system (MNS) and resting state networks (RSN), reflected specifically in the Insula, Anterior Cingulate Cortex (ACC), Precuneus, Posterior Cingulate Cortex (PCC), Amygdala, Bilateral Inferior Parietal Cortex, Primary Motor-Visual System, and Dorsal Medulla while viewing touch with lovingkindness meditation lovingkindness meditation vs no lovingkindness meditation, receiving touch with lovingkindness meditation vs no lovingkindness meditation and both viewing and receiving touch with lovingkindness meditation vs no lovingkindness meditation. This is a descriptive study to generate sample size estimates for an NIH RO1 proposal. ;

Study Design

Related Conditions & MeSH terms

Central Nervous System

Clinical Trial Details

NCT number	NCT01432288
Study type	Observational
Source	Wake Forest University Health Sciences
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04014491` - The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome	N/A
Terminated	`NCT01006109` - Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
Recruiting	`NCT02559752` - Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Completed	`NCT01531920` - A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel	Phase 1
Completed	`NCT02652260` - Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)	Phase 2
Recruiting	`NCT01541800` - Circulating microRNAs as Disease Markers in Pediatric Cancers	N/A
Completed	`NCT02343718` - Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours	Phase 1
Completed	`NCT03430427` - Brain Networks and Mobility Function: B-NET
Completed	`NCT03830762` - Xanamem™ in Healthy Elderly Subjects	Phase 1
Completed	`NCT01527006` - Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs	Phase 2
Completed	`NCT01517087` - Studying Motor Neuron Tests
Recruiting	`NCT05627986` - Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome
Completed	`NCT00067067` - Investigating Endothelial Precursor Cells (EPCs)	N/A
Completed	`NCT03268239` - Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions	N/A
Recruiting	`NCT04846764` - Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Touch and Attention MRI Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms